VENTURIS THERAPEUTICS
Venturis Therapeutics specializes in pre-clinical therapeutic programs for diabetic wounds and cardiovascular diseases using protein drugs.
VENTURIS THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.venturistherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1-972-904-2029
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Analytics Global Site Tag ReCAPTCHA Google Universal Analytics
Similar Organizations
Burke Therapeutics
Burke Therapeutics specializes in providing prescription products for conditions patients live with each and every day.
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Penrose TherapeuTx
Penrose TherapeuTx specializes in technological advancements for treating advanced cancers using small-molecule therapies.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
TRPBlue
TRPBlue specializes in topical therapeutics for the effective prevention and treatment of chemotherapy-induced peripheral neuropathy.
Official Site Inspections
http://www.venturistherapeutics.com Semrush global rank: 8.35 M Semrush visits lastest month: 558
- Host name: redirect2.proxy-ssl.webflow.com
- IP address: 34.193.69.252
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Venturis Therapeutics"
venturistherapeutics.com Reviews: Is this site a scam or legit?
Organization Domains By Proxy, LLC ... In the context of venturistherapeutics.com, our investigation continues working to pinpoint the specific category, but we welcome your insights …See details»
Leadership - Venturis Therapeutics
Dr. Sherman earned his Bachelor of Science from MIT and Doctorate in Medicine from SUNY Upstate Medical Center in 1977. Following an internal medicine residency in Rochester, NY …See details»
Venturis Therapeutics, Inc. | LinkedIn
Venturis Therapeutics, Inc. | 186 followers on LinkedIn. Advancing novel therapeutics utilizing regenerative medicine to address unmet needs | Venturis Therapeutics, Inc is a clinical stage bio ...See details»
Venturis Therapeutics - Crunchbase Company Profile
Venturis Therapeutics specializes in pre-clinical therapeutic programs for diabetic wounds and cardiovascular diseases using protein drugs.See details»
Investors - Venturis Therapeutics
Pursuant to its charter, the compensation committee will provide assistance to the Board of Directors by designing, recommending to the Board of Directors for approval and evaluating …See details»
Venturis Therapeutics - 2025 Company Profile - Tracxn
Mar 22, 2025 Venturis Therapeutics is an unfunded company based in Dallas (United States), founded in 2019 by Grant Gordon. It operates as a Developer of drugs for treating diseases …See details»
Venturis Therapeutics Org Chart + Executive Team - The Official …
For each of our 1,292,083 listed executives, discover their exact roles and their biographies.See details»
Venturis Therapeutics - Biotech Careers
Venturis Therapeutics (formerly Cardiovascular Biotherapeutics) is a clinical stage biopharmaceutical company advancing novel therapeutics to address diseases such as …See details»
Venturis Therapeutics - Craft
Venturis Therapeutics (formerly known as Cardiovascular Biotherapeutics) is a biopharmaceutical company. It develops protein drug candidates to address diseases such as severe coronary …See details»
Venturis Therapeutics - Contacts, Employees, Board Members, …
Venturis Therapeutics specializes in pre-clinical therapeutic programs for diabetic wounds and cardiovascular diseases using protein drugs.See details»
Venturis Therapeutics - Products, Competitors, Financials, …
Venturistherapeutics.com. Overview & Products; People; About Venturis Therapeutics. Venturis Therapeutics is a clinical stage biopharmaceutical company that develops protein drug …See details»
Venturis Therapeutics | VentureRadar
LucasPye Bio USA n/a As a Contract Development Manufacturing Organization (CDMO), we fast-track the clinical development of your biologic for regulatory approval, manufacture your …See details»
Venturis Therapeutics, Inc | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Venturis Therapeutics CEO and Key Executive Team | Craft.co
Venturis Therapeutics's CFO is Robert Schleizer. Other executives include Calvin Wallen, Chairman; Grant Gordon, Director and 4 others. See the full leadership team at Craft.See details»
A positive new chapter in the life of the Company - Webflow
Venturis Therapeutics - A positive new chapter in the life of the Company January 07, 2020 Dallas, TX January 7th, 2020 – Venturis Therapeutics, Inc. (“VT” or the “Company”) today …See details»
A positive new chapter in the life of the Company - LinkedIn
Feb 13, 2020 Dallas, TX January 7th, 2020 – Venturis Therapeutics, Inc. (“VT” or the “Company”) today announced that effective today January 7th, 2020, Cardiovascular …See details»
Venturis Therapeutics, Inc. Announces Strategic Alliance with …
September 9, 2021 2626 Cole Ave., Suite 300 Dallas, TX (972) 681-9368 www.venturistherapeutics.com Venturis Therapeutics, Inc. Announces Strategic Alliance with …See details»
Cardiovascular Biotherapeutics - Overview, News & Similar
Aug 31, 2018 Cardiovascular Biotherapeutics contact info: Phone number: (972) 681-9368 Website: www.venturistherapeutics.com What does Cardiovascular Biotherapeutics do? …See details»
Venturis Therapeutics - VentureRadar
LucasPye Bio USA n/a As a Contract Development Manufacturing Organization (CDMO), we fast-track the clinical development of your biologic for regulatory approval, manufacture your …See details»
Novartis receives FDA accelerated approval for Vanrafia® …
2 days ago Ad hoc announcement pursuant to Art. 53 LR. Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS …See details»